New treatment offered for bone metastasis
Taipei, July 9 (CNA) The Taipei Cancer Center said Wednesday that it is offering a new noninvasive treatment for bone metastasis that it said offers lasting pain relief without radiation.
The center, which is affiliated with Taipei Medical University, said that it began treatments back in late May using ExAblate, a device developed by Israeli company InSightec Ltd., which uses MR-guided focused ultrasound surgery technology.
The cancer center said it is the first in Taiwan to use the ExAblate device.
"So far, eight patients have undergone the new type of treatment," the center told CNA.
"We are excited to offer our patients a new and noninvasive course of treatment," said Chiu Hung-yi, vice superintendent of the Taipei Cancer Center, last week in a statement to officially mark cooperation with InSightec.
The treatment offers quick and lasting pain relief without radiation, Chiu said, adding that most patients have reported pain relief within days.
"We look forward to working with Taipei Cancer Center to lead the way to offering non-invasive solutions for a wide variety of indications," said Roni Yagel of InSightec in the statement.
Bone metastases occur when cancer cells spread from their primary site to other parts of the body. More than two-thirds of breast and prostate cancer cases spread to the bones, InSightec said.
Pain is the most severe symptom and pain medications and palliative radiation therapy are the most common treatments prescribed, it said. But up to 30 percent of patients either do not respond to radiation therapy or are unable to undergo radiation for pain relief, it added.
(By Elaine Hou)ENDITEM/WH
U.S. dollar down in Taipei trading06/01/2020 10:28 AM
Taiwan shares open higher06/01/2020 09:14 AM
Seas around Taiwan to be center of military movements: defense analyst05/31/2020 09:33 PM
New Taipei light rail system to offer mobile payment discount05/31/2020 08:39 PM
Hot weather, occasional showers forecast for coming week: CWB05/31/2020 08:35 PM